Search by Drug Name or NDC
NDC 37000-0477-12 Pepto-Bismol 262 mg/1 Details
Pepto-Bismol 262 mg/1
Pepto-Bismol is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by The Procter & Gamble Manufacturing Company. The primary component is BISMUTH SUBSALICYLATE.
MedlinePlus Drug Summary
Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
Related Packages: 37000-0477-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bismuth Subsalicylate
Product Information
NDC | 37000-0477 |
---|---|
Product ID | 37000-477_e5f8d36d-6c56-08bf-e053-2a95a90afdc5 |
Associated GPIs | |
GCN Sequence Number | 002860 |
GCN Sequence Number Description | bismuth subsalicylate TAB CHEW 262 MG ORAL |
HIC3 | D6D |
HIC3 Description | ANTIDIARRHEALS |
GCN | 08420 |
HICL Sequence Number | 001246 |
HICL Sequence Number Description | BISMUTH SUBSALICYLATE |
Brand/Generic | Brand |
Proprietary Name | Pepto-Bismol |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bismuth subsalicylate |
Product Type | HUMAN OTC DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 262 |
Active Ingredient Units | mg/1 |
Substance Name | BISMUTH SUBSALICYLATE |
Labeler Name | The Procter & Gamble Manufacturing Company |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | M008 |
Listing Certified Through | 2023-12-31 |
Package
NDC 37000-0477-12 (37000047712)
NDC Package Code | 37000-477-12 |
---|---|
Billing NDC | 37000047712 |
Package | 2 CELLO PACK in 1 CARTON (37000-477-12) / 6 TABLET in 1 CELLO PACK |
Marketing Start Date | 2004-06-30 |
NDC Exclude Flag | N |
Pricing Information | N/A |